High Vista Strategies LLC Novo Nordisk A S Transaction History

High Vista Strategies LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$67.66 - $84.76 $345,945 - $433,377	-5,113 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$67.06 - $75.82 $173,148 - $195,767	-2,582 Reduced 33.55%	5,113 $345,000
Q4 2020 Feb 16, 2021	BUY	$63.89 - $73.8 $38,014 - $43,911	595 Added 8.38%	7,695 $537,000
Q3 2020 Nov 16, 2020	SELL	$63.69 - $70.22 $19,107 - $21,066	-300 Reduced 4.05%	7,100 $493,000
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $111,226 - $129,086	-1,900 Reduced 20.43%	7,400 $485,000
Q1 2020 May 15, 2020	SELL	$49.46 - $64.78 $870,496 - $1.14 Million	-17,600 Reduced 65.43%	9,300 $560,000
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $573,390 - $669,990	-11,500 Reduced 29.95%	26,900 $1.56 Million
Q3 2019 Nov 14, 2019	BUY	$47.54 - $53.43 $185,406 - $208,377	3,900 Added 11.3%	38,400 $1.99 Million
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $135,691 - $152,163	-2,900 Reduced 7.75%	34,500 $1.76 Million
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $236,436 - $268,413	-5,100 Reduced 12.0%	37,400 $1.96 Million
Q4 2018 Feb 14, 2019	SELL	$41.54 - $47.25 $502,634 - $571,725	-12,100 Reduced 22.16%	42,500 $1.96 Million
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $224,448 - $245,952	4,800 Added 9.64%	54,600 $2.57 Million
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $757,359 - $862,182	17,100 Added 52.29%	49,800 $2.3 Million
Q1 2018 May 15, 2018	BUY	$48.49 - $58.14 $63,037 - $75,582	1,300 Added 4.14%	32,700 $1.61 Million
Q4 2017 Feb 14, 2018	BUY	$47.53 - $53.73 $1.49 Million - $1.69 Million	31,400	31,400 $1.69 Million

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.